The FDA has approved Venetoclax in combination with either low-dose Cytarabine (LDAC), Azacytidine or Decitabine for the treatment of newly diagnosed AML patients who do not qualify for intensive induction chemotherapy or are over 75 years old 11
Treatment sessions are 10-20 minutes long and can be conveniently scheduled around a typical daily schedule
6 In trauma patients, the risk of pulmonary complications, such as respiratory failure requiring mechanical ventilation, is higher if there is a history of alcohol abuse
Nanoemulsions (O/W) containing Cymbopogon pendulus essential oil: development, characterization, stability study, and evaluation of in vitro anti-bacterial, anti-inflammatory, anti-diabetic activities
Organic mercury is more likely to cause health issues than inorganic mercury
TANs and tumor nave neutrophils were isolated from bone marrow of tibia using Mojosort negative selection (Biolegend 480,057)